TY  - GEN
AU  - Alvarez-Twose,I
AU  - Martínez-Barranco,P
AU  - Gotlib,J
AU  - García-Montero,A
AU  - Morgado,J M
AU  - Jara-Acevedo,M
AU  - Merker,J D
AU  - Peñalver,F J
AU  - Matito,A
AU  - Hou,Y
AU  - Sánchez-Muñoz,L
AU  - Mayado,A
AU  - Mollejo,M
AU  - Escribano,L
AU  - Orfao,A
TI  - Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia
SN  - 1476-5551
PY  - 2018///0209
KW  - Aged
KW  - Aminoglycosides
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents, Immunological
KW  - Female
KW  - Gemtuzumab
KW  - Humans
KW  - Leukemia, Mast-Cell
KW  - drug therapy
KW  - Neoplasm Recurrence, Local
KW  - Salvage Therapy
KW  - methods
N1  - Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2016.30
ER  -